Chemokine Therapeutics Corp. Announces Breast Cancer Data Presented at a Metastasis Conference With Lead Compound, CTCE-9908

Published: Aug 06, 2008

VANCOUVER, BRITISH COLUMBIA--(Marketwire - August 06, 2008) - Chemokine Therapeutics Corp. ("Chemokine Therapeutics" or the "Company") (TSX: CTI)(OTCBB: CHKT), a biotechnology company developing chemokine-based therapies to treat cancer, blood disorders, and vascular disease today announced that research results were presented yesterday by the laboratory of Dr. Danny R. Welch, President of the Metastasis Research Society and Professor of Pathology, Cell Biology and Pharmacology, University of Alabama at Birmingham, at the Joint Metastasis Research Society (MRS) - American Association for Cancer Research (AACR) Conference on Metastasis held in Vancouver, B.C., Canada.

Back to news